Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus conversion after kidney transplantation for cardiac hypertrophy and carotid atherosclerosis
RBR-26qdtgPhase 4Recruiting
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina de Botucatu
- Start
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of everolimus in left ventricular hypertrophy (LVH) and carotid atheroma (CAS) (2 arms), sponsored by Hospital das Clínicas da Faculdade de Medicina de Botucatu. Started May 2012; status: recruiting.
02
Drugs
everolimus
03
Conditions
left ventricular hypertrophy (LVH)carotid atheroma (CAS)
Beyond the preview
Go deeper on RBR-26qdtg.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-26qdtg.